It is the cache of http://www.dovepress.com/the-effect-of-topical-005-cyclosporine-on-recurrence-following-pterygi-a7756. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

The effect of topical 0.05% cyclosporine on recurrence following ptery
skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

14789

The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery



Original Research

(5819) Total Article Views


Authors: Turan-Vural E, Torun-Acar BT, Kivanc SA, Acar S

Published Date June 2011 Volume 2011:5 Pages 881 - 885
DOI: http://dx.doi.org/10.2147/OPTH.S19469

Ece Turan-Vural¹, Banu Torun-Acar¹, S Argun Kivanc², Suphi Acar¹
¹Haydarpaşa Numune Education and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey; ²Umranıye Education and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey

Purpose: To investigate the role of postoperative topical 0.05% cyclosporine A (CsA) eye drops (Restasis®, Allergan Pharmaceutical) in the prevention of recurrence among patients with primary pterygium treated with bare-sclera technique.
Methods: In this prospective randomized controlled study, 36 eyes (34 patients) with primary pterygium were randomized into two groups: Group I comprised 18 eyes (18 patients), and Group II comprised 18 eyes (16 patients). Bare sclera technique was performed in both groups. In Group I, 0.05% CsA was administered postoperatively at 6-hour intervals for 6 months, and Group II did not receive any cyclosporine treatment. The patients were assessed for recurrence, side effects, and complications at postoperative 1 and 7 days as well as each month during the following year. Conjunctival advances which showed a limbus higher than 1 mm were recognized as recurrence.
Results: Recurrence occurred in four patients (22.2%) in Group I and in eight (44.4%) patients in Group II.
Conclusion: Postoperative application of low-dose CsA can be effective for preventing recurrences after primary pterygium surgery.

Keywords: primary pterygium, cyclosporine A, bare sclera



Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter

 

Other articles by Dr Ece Turan-Vural


Readers of this article also read: